Physician-scientist laboratory seeking students interested in translational research in blood cancers.
Our lab studies cell signaling and epigenetic pathways in an aggressive form of bone marrow cancer called acute myeloid leukemia (AML). Our primary focus is on a subtype of AML with mutations in FLT3, which confer a worse prognosis. FLT3 inhibitors are effective, but not curative in FLT3 mutated AML. The overall goal of the lab is to develop better therapies to improve patient outcomes. We use techniques in molecular biology, flow cytometry, cell culture, and mouse models.
The specific outcomes of this project will be identified by the faculty mentor at the beginning of your collaboration.
|Length of commitment||To be determined by the student/mentor |
|Start time||Fall (August/September) |
|In-person, remote, or hybrid?||In-Person Project|
|Level of collaboration||Individual student project |
|Benefits||Academic credit |
|Who is eligible||All undergraduate students|
Once you begin the digital badge series, you will have access to all the necessary activities and instructions. Your mentor has indicated they would like you to also complete the specific preparation activities below. Please reference this when you get to Step 2 of the Preparation Phase.
The specific preparation activities for this project will be customized through discussions between you and your project mentor. Please be sure to ask them for the instructions to complete the required preparation activities.
Cancer, Pharmacology, Therapeutics, Roswell